Document Details

MGEN $9.02   $ (0.03) (0.33)%
Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 3/24/2017
Filing Date 3/30/2017

Abstract: 8-K filed by Miragen Therapeutics covering Changes in Registrant's Certifying Accountant; Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; and Financial Statements and Exhibits.
Download

File Section(s)

  1. 8-K
  2. EX-16.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.